This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Helixmith Co., Ltd. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Dongsik Kim: Innovator in Pharmaceutical Treatments
Introduction
Dongsik Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments utilizing anti-c-Met antibodies. His innovative work aims to address various diseases through targeted therapies.
Latest Patents
Dongsik Kim holds 1 patent for his invention titled "Methods of treatment using anti-c-met antibodies." This patent describes a pharmaceutical composition designed to prevent or treat a variety of diseases by activating c-Met in cells through the use of the anti-c-Met antibody, which functions as a c-Met agonist. The invention highlights a method for leveraging c-Met activation to combat various health conditions effectively.
Career Highlights
Throughout his career, Dongsik Kim has been associated with Helixmith Co., Ltd., a company focused on innovative biopharmaceutical solutions. His work at Helixmith has positioned him as a key player in the development of advanced therapeutic strategies.
Collaborations
Dongsik Kim has collaborated with notable colleagues, including Seung Shin Yu and Jae-Gyun Jeong. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Dongsik Kim's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to inspire advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile